Investor Presentaiton slide image

Investor Presentaiton

BIOND BIOLOGICS Experienced leadership Tehila Ben Moshe, PhD CEO CCAM PROTALIXX Biotherapeutics Biotherapeutics Ori Shilo, MBA CFO Red Hill Biopharma ProSeed Capital Holdings CVA Avidor Shulman, PhD VP R&D PROTALIXX Biotherapeutics Itay Friedman, MD VP Clinical Development Bristol-Myers Squibb Biond Biologics Corporate Presentation | May 2021 | Non-confidential Yair Sapir, PhD COO CCAM Biotherapeutics 4
View entire presentation